1,909 research outputs found

    Multiple memory systems, multiple time points: how science can inform treatment to control the expression of unwanted emotional memories.

    Get PDF
    Memories that have strong emotions associated with them are particularly resilient to forgetting. This is not necessarily problematic, however some aspects of memory can be. In particular, the involuntary expression of those memories, e.g. intrusive memories after trauma, are core to certain psychological disorders. Since the beginning of this century, research using animal models shows that it is possible to change the underlying memory, for example by interfering with its consolidation or reconsolidation. While the idea of targeting maladaptive memories is promising for the treatment of stress and anxiety disorders, a direct application of the procedures used in non-human animals to humans in clinical settings is not straightforward. In translational research, more attention needs to be paid to specifying what aspect of memory (i) can be modified and (ii) should be modified. This requires a clear conceptualization of what aspect of memory is being targeted, and how different memory expressions may map onto clinical symptoms. Furthermore, memory processes are dynamic, so procedural details concerning timing are crucial when implementing a treatment and when assessing its effectiveness. To target emotional memory in its full complexity, including its malleability, science cannot rely on a single method, species or paradigm. Rather, a constructive dialogue is needed between multiple levels of research, all the way 'from mice to mental health'.This article is part of a discussion meeting issue 'Of mice and mental health: facilitating dialogue between basic and clinical neuroscientists'.We are grateful to the Royal Society for their support of the costs of attending this meeting ‘Of mice and mental health: facilitating dialogue between basic and clinical neuroscientists' convened by Amy L. Milton and Emily A. Holmes. R.M.V. is supported by the European Union's Horizon 2020 research and innovation programme under grant agreement no. 705641 (SUAI/023/RG92025). A.L.-Z. was supported by a Cambridge International Scholarship awarded by the Cambridge Commonwealth, European and International Trust. R.N.H. is supported by the UK Medical Research Council Programme (SUAI/010/ RG91365). E.A.H. receives support from the Karolinska Institutet and the Lupina Foundation. Funding to pay the Open Access publication charges for this article was provided by the UK Medical Research Council (SUAI/013/ RG91365)

    Synthetic Control of the Photoluminescence Stability of Organolead Halide Perovskites

    Get PDF
    An optimized synthetic procedure for preparing photostable nanocrystalline methylammonium lead halide materials is reported. The procedure was developed by adjusting the lead halide to methylammonium/octylammonium halide precursor ratio. At a high precursor ratio (1:3), a blue-shifted photoinduced luminescence peak is measured at 642 nm for CH3NH3PbI3 with 0.01 to 12 mJ pulsed-laser irradiation. The appearance of this peak is reversible over 300 min upon blocking the irradiation. In order to determine if the peak is the result of a phase change, in situ x-ray diffraction measurements were performed. No phase change was measured with an irradiance that causes the appearance of the photoinduced luminescence peak. Luminescence microscpectroscopy measurements showed that the use of a lower precursor ratio (1:1.5) produces CH3NH3PbI3 and CH3NH3PbBr3 perovskites that are stable over 4 min of illumination. Given the lack of a measured phase change, and the dependence on the precursor ratio, the photoinduced luminesce peak may derive from surface trap states. The enhanced photostability of the resulting perovskite nanocrystals produced with the optimized synthetic procedure supports their use in stable optoelectronic devices

    Selectively Interfering With Intrusive but Not Voluntary Memories of a Trauma Film: Accounting for the Role of Associative Memory

    Get PDF
    Intrusive memories of a traumatic event can be reduced by a subsequent interference procedure, seemingly sparing voluntary memory for that event. This selective-interference effect has potential therapeutic benefits (e.g., for emotional disorders) and legal importance (e.g., for witness testimony). However, the measurements of intrusive memory and voluntary memory typically differ in the role of associations between a cue and the emotional memory “hotspots.” To test this, we asked participants to watch a traumatic film followed by either an interference procedure (reminder plus Tetris) or control procedure (reminder only). Measurement of intrusions (using a laboratory task) and voluntary memory (recognition for film stills) were crossed with the presence or absence of associative cues. The reminder-plus-Tetris group exhibited fewer intrusions despite comparable recognition memory, replicating the results of prior studies. Note that this selective interference did not appear to depend on associative cues. This involuntary versus voluntary memory dissociation for emotional material further supports separate-trace memory theories and has applied advantages

    Long-Term Consequences of Methamphetamine Exposure in Young Adults Are Exacerbated in Glial Cell Line-Derived Neurotrophic Factor Heterozygous Mice

    Get PDF
    Methamphetamine abuse in young adults has long-term deleterious effects on brain function that are associated with damage to monoaminergic neurons. Administration of glial cell line-derived neurotrophic factor (GDNF) protects dopamine neurons from the toxic effects of methamphetamine in animal models. Therefore, we hypothesized that a partial GDNF gene deletion would increase the susceptibility of mice to methamphetamine neurotoxicity during young adulthood and possibly increase age-related deterioration of behavior and dopamine function. Two weeks after a methamphetamine binge (4 x 10 mg/kg, i.p., at 2 h intervals), GDNF +/- mice had a significantly greater reduction of tyrosine hydroxylase immunoreactivity in the medial striatum, a proportionally greater depletion of dopamine and 3,4-dihydroxyphenylacetic acid (DOPAC) levels in the striatum, and a greater increase in activated microglia in the substantia nigra than wild-type mice. At 12 months of age, methamphetamine-treated GDNF +/- mice exhibited less motor activity and lower levels oftyrosine hydroxylase-immunoreactivity, dopamine, DOPAC, and serotoninthanwild-typemice. Greater striatal dopaminetransporter activity in GDNF +/- mice may underlie their differential response to methamphetamine. These data suggest the possibility that methamphetamine use in young adults, when combined with lower levels of GDNF throughout life, may precipitate the appearance of parkinsonian-like behaviors during aging
    corecore